Capsulin oral insulin administered twice a day at a dose of 150iu per capsule is a safe and efficient treatment option for people with type 2 diabetes, new research demonstrates. Scientists have ...
Individuals on SGLT2 inhibitors are 37 per cent less likely to develop kidney disease or acute kidney injury compared to those not taking the medication, new evidence shows. A team of researchers ...
High blood glucose levels are associated with an increased number of root caries in adults with or without type 2 diabetes, latest research demonstrates. During the study, a total of 39 adults ...
The use of SGLT2 inhibitors was associated with a reduced risk of heart failure in people living with cancer and diabetes, according to research published in the British Medical Journal. The ...
A new study has found an association between good type 1 diabetes management and the use of GLP-1RA receptor agonists and SGLT2 inhibitors in real-world practice. During the experiment, a team of ...
Gestational diabetes is associated with more diverse cardiovascular outcomes than previously considered, latest research suggests. A team of academics used multivariable Cox proportional hazard ...
GLP-1 receptor agonists and SGLT-2 inhibitors are more beneficial than sulfonylureas for people with chronic obstructive pulmonary disease and type 2 diabetes, according to research published in ...
Three health organisations have appointed 17 leading international scientists to advise on its £50 million investment into type 1 diabetes research. The Steve Morgan Foundation, Diabetes UK and ...
Adolescents living with obesity can reduce their body weight by taking a once-weekly treatment of a 2.4-mg dose of semaglutide alongside following a healthy lifestyle, according to a study ...
The evolution of diabetes-related technologies was discussed by a former optometrist in the latest online interview for the Diabetes Times. Jenny Hirst, Co-Founder of the charity InDependent ...